Natural Alternatives International Announces New Website Launch To Support Market Expansion Initiative into Healthy Aging & Everyday Wellness
CARLSBAD, Calif., Nov. 5, 2018 /PRNewswire/ — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) is pleased to announce the launch of a new website to promote the SR CarnoSyn® beta-alanine market expansion into the healthy aging and general wellness markets. The newly designed website offers insightful information on the top five health benefits of SR CarnoSyn®, research, product formats, FAQs and contact information.
NAI will debut the healthy aging & wellness expansion at SupplySide West in Las Vegas, November 8-9, 2018. Dr. Jay Hoffman will be a featured guest at NAI’s booth #4933 on November 8th, from 10:00 am – 12:00 pm, and will be available to speak to industry contacts who are seeking to learn more about the latest advances with SR CarnoSyn® in the general wellness and healthy aging. “We are excited about our new website launch and supporting sales collateral,” stated Nicole Burbank, CarnoSyn® Brands Vice President. “NAI is aggressively pursuing partnerships with key players in the general wellness and healthy aging markets to provide unique SR CarnoSyn® product offerings to the supplement and specialty food categories. SupplySide West will provide a good starting point for this endeavor.”
The new website has a clean, modern design and will allow visitors to have a very informative experience as the brand continues to grow and increase market presence. NAI invites visitors to explore the website and to sign up for direct emails from the company at www.srcarnosyn.com.
About CarnoSyn® Brands:
CarnoSyn® Brands feature two clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine and SR CarnoSyn® sustained release beta-alanine. In the sports nutrition segment, both ingredients are well known to deliver benefits for athletic performance: Increased strength, enhanced endurance, faster recovery, and greater mental focus.
SR CarnoSyn® is an advanced delivery form of CarnoSyn®, which delivers higher dosing levels of beta-alanine, and is proven to provide benefits for both brain health and muscle function and capacity. In 2017, SR CarnoSyn® was determined to be safe through independent scientific procedures, thus satisfying the technical element of the Generally Recognized as Safe (GRAS) determination. The GRAS affirmation allows NAI to broaden their product offerings beyond the sports nutrition space and focus on the dietary supplement and food and beverage industries, including medical and other fortified food products. CarnoSyn® and SR CarnoSyn® are ultra-pure amino acids and banned substance free, backed by NAI’s commitment to the highest quality, potency, and manufacturing standards. For more information about CarnoSyn® and SR CarnoSyn®, please visit www.carnosyn.com and www.srcarnosyn.com.
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please visit www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our future revenue profits and financial condition, our ability to maintain our patents, generate revenues from the commercialization of our patents and trademarks, secure compliance with our intellectual property rights, and develop, maintain or increase sales to new and existing customers, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks, including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.